This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa; a multicentre study.Thromb Haemost. 1997;78:1436–1437.
Shirahata A, Kamiya T, Takamatsu J, et al. Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitors.Int J Hematol. 2001;73:517–525.
Macik BG, Lindley CM, Lusher J, et al. Safety and initial efficacy of three dose levels of recombinant activated factor VII (rVIIa): results of a phase I study.Blood Coagul Fibrinolysis. 1993;4:521–5277.
Carr ME, Martin EJ, Carr SL. Delayed, reduced and inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.Blood Coagul Fibrinolysis. 2002;13:193–1977.
Friederich PW, Levi M, Bauer KA, et al. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.Circulation. 2001;103:2555–2559.
Smith LG, Kitchens CS. Pseudo-prolongation of the partial thromboplastin time.Am J Clin Pathol. 1983;80:750–752.
Konle BA. Clinical use and laboratory monitoring of recombinant factor VIIa (NovoSeven“). Presented at: Hemostasis and Thrombosis Update 2001; April 26-28, 2001; Temple University School of Medicine, Philadelphia, Pa.
Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U. Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.Haemophilia. 2001;7:517–522.
About this article
Cite this article
Carr, M.E., Kuhn, J.G., Martin, E.J. et al. Pseudoprolongation of the Prothrombin Time During Treatment with Recombinant Factor VIIa for Bleeding in a Patient with a Spontaneous Factor VIII Inhibitor. Int J Hematol 77, 308–309 (2003). https://doi.org/10.1007/BF02983792
- Prothrombin Time
- Recombinant Factor VIIa
- FVIII Inhibitor